Annual Report 2024 published
Annual Report 2024 published.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today published the Annual Report for 2024. The Annual Report contains the Report of the Board of Directors, the Financial Statements for 2024 and the Remuneration Report.
The English version of Annual Report is available as a PDF file attached to this release and on the company's website at https://faron.com/investors/reports-and-presentations/. Finnish language version of the Financial Statements is available as a PDF file attached to this release and on the company's website at https://faron.fi/sijoittajat/raportit-esitykset/.
Faron Pharmaceuticals Ltd
Board of Directors
About Bexmarilimab
About Faron Pharmaceuticals Ltd.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.